[Adverse reactions after vaccination against influenza in chronically ill people].

Abstract

The objective was to assess the early and late adverse reactions after vaccination against influenza with the help of SmithKline Beecham's Fluarix vaccine in chronically ill people. 1010 people was selected to undergo vaccination. These included 621 woman aged average 44.2 and 389 men aged average 48.2. The vaccination was conducted simultaneously and the period of monitoring adverse reactions lasted 9 months. The vaccination was done in accordance with recommendations of manufacturer. All the vaccinated people suffered from circulatory system disorders, bone system disorders, mental disorders and endocrinological problems, during the vaccination they were in period of remission. The observed early symptoms fell into two categories: local and general. The late adverse reaction assessed with appearance of aggravation of main chronic disease or with appearance of the new chronic disease. The local symptoms included swelling, reddening and pain in the vaccinated area. 67 people (6.6%) reported swelling, 85 (8.4%) reported reddening, 12 people (1.2%) reported pain in the vaccinated area. The general symptoms included headache, bad mood and temperature over 37.5 degrees C. 19 people (1.9%) reported bad mood, 10 people (1%)--headache and 8 people (0.8%) reported temperature over 37.5 degrees C. Coexistence of two or three types of symptoms was present in 15 cases (1.5%). There were no late adverse reactions in the study group. The low percentage of early adverse reactions and no late adverse reactions encourages a wider use of vaccines against influenza in chronically ill people.

• Authors: Andrzej Gałaj, Grzegorz Grześk, Arkadiusz Kuziemski, Leszek Szadujkis-Szadurski, Thabit Sinjab
• Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (Pol Merkur Lekarski) Vol. 12 Issue 72 Pg. 496-9 (Jun 2002) ISSN: 1426-9686 [Print] Poland
• Vernacular Title: Objawy niepozadane u przewlekle chorych po szczepieniu przeciwko grypie.
• PMID: 12362669 (Publication Type: English Abstract, Journal Article)

Chemical References

• Influenza Vaccines

Topics

• Adult
• Affect
• Aged
• Chronic Disease (epidemiology)
• Erythema (chemically induced)
• Female
• Fever (chemically induced)
• Humans
• Influenza Vaccines (adverse effects, therapeutic use)
• Influenza, Human (epidemiology, prevention & control)
• Male
• Middle Aged
• Pain (chemically induced)
• Poland (epidemiology)
• Time Factors